McCairn Kevin W, Turner Robert S
Department of Neurological Surgery, University of California, San Francisco, California; Department of Biological Sciences, Milton Keynes, The Open University, Buckinghamshire, United Kingdom; and
Department of Neurological Surgery, University of California, San Francisco, California; Department of Neurobiology and Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, Pennsylvania.
J Neurophysiol. 2015 Apr 1;113(7):2537-48. doi: 10.1152/jn.00701.2014. Epub 2015 Feb 4.
Although there is general consensus that deep brain stimulation (DBS) yields substantial clinical benefit in patients with Parkinson's disease (PD), the therapeutic mechanism of DBS remains a matter of debate. Recent studies demonstrate that DBS targeting the globus pallidus internus (GPi-DBS) suppresses pathological oscillations in firing rate and between-cell spike synchrony in the vicinity of the electrode but has negligible effects on population-level firing rate or the prevalence of burst firing. The present investigation examines the downstream consequences of GPi-DBS at the level of the primary motor cortex (M1). Multielectrode, single cell recordings were conducted in the M1 of two parkinsonian nonhuman primates (Macaca fasicularis). GPi-DBS that induced significant reductions in muscular rigidity also reduced the prevalence of both beta (12-30 Hz) oscillations in single unit firing rates and of coherent spiking between pairs of M1 neurons. In individual neurons, GPi-DBS-induced increases in mean firing rate were three times more common than decreases; however, averaged across the population of M1 neurons, GPi-DBS induced no net change in mean firing rate. The population-level prevalence of burst firing was also not affected by GPi-DBS. The results are consistent with the hypothesis that suppression of both pathological, beta oscillations and synchronous activity throughout the cortico-basal ganglia network is a major therapeutic mechanism of GPi-DBS.
尽管人们普遍认为深部脑刺激(DBS)对帕金森病(PD)患者有显著的临床益处,但DBS的治疗机制仍存在争议。最近的研究表明,靶向苍白球内侧部的DBS(GPi-DBS)可抑制电极附近放电率的病理性振荡以及细胞间的尖峰同步性,但对群体水平的放电率或爆发性放电的发生率影响可忽略不计。本研究在初级运动皮层(M1)水平上研究了GPi-DBS的下游效应。在两只患帕金森病的非人灵长类动物(食蟹猴)的M1区进行了多电极单细胞记录。能显著降低肌肉僵硬程度的GPi-DBS,也降低了单个神经元放电率中β(12 - 30Hz)振荡以及M1神经元对之间的相干放电的发生率。在单个神经元中,GPi-DBS引起的平均放电率增加比降低更为常见;然而,在M1神经元群体中进行平均时,GPi-DBS并未引起平均放电率的净变化。爆发性放电的群体水平发生率也不受GPi-DBS的影响。这些结果与以下假设一致,即抑制整个皮质-基底神经节网络中的病理性β振荡和同步活动是GPi-DBS的主要治疗机制。